| ISIN | LU1776393032 |
|---|---|
| Valor Number | |
| Bloomberg Global ID | |
| Fund Name | Crossfund Sicav-Crossinvest Swiss Opportunity Fund A EUR |
| Fund Provider |
Crossinvest SA
Lugano, Switzerland Phone: +41 91 911 88 88 E-Mail: info@crossinvest.ch Web: www.crossinvest.ch |
| Fund Provider | Crossinvest SA |
| Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
| Distributor(s) |
FundPartner Solutions (Suisse) SA Genève 3 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The investment objective of the Sub-Fund is to achieve a long term capital growth in Swiss Francs by pursuing exposure opportunities to the Swiss market. The Sub-Fund is actively managed. The Sub-Fund has no benchmark index and is not managed in reference to a benchmark index. |
| Peculiarities |
| Current Price * | 162.63 EUR | 13.01.2026 |
|---|---|---|
| Previous Price * | 163.61 EUR | 12.01.2026 |
| 52 Week High * | 163.78 EUR | 09.01.2026 |
| 52 Week Low * | 135.96 EUR | 09.04.2025 |
| NAV * | 162.63 EUR | 13.01.2026 |
| Issue Price * | 162.63 EUR | 13.01.2026 |
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 44,784,207 | |
| Unit/Share Assets *** | 1,138,714 | |
| Trading Information SIX | ||
| YTD Performance | +0.84% |
31.12.2025 - 13.01.2026
31.12.2025 13.01.2026 |
|---|---|---|
| YTD Performance (in CHF) | +0.98% |
31.12.2025 - 13.01.2026
31.12.2025 13.01.2026 |
| 1 month | +2.39% |
15.12.2025 - 13.01.2026
15.12.2025 13.01.2026 |
| 3 months | +5.65% |
13.10.2025 - 13.01.2026
13.10.2025 13.01.2026 |
| 6 months | +8.71% |
14.07.2025 - 13.01.2026
14.07.2025 13.01.2026 |
| 1 year | +12.86% |
13.01.2025 - 13.01.2026
13.01.2025 13.01.2026 |
| 2 years | +23.75% |
15.01.2024 - 13.01.2026
15.01.2024 13.01.2026 |
| 3 years | +25.03% |
13.01.2023 - 13.01.2026
13.01.2023 13.01.2026 |
| 5 years | +20.80% |
13.01.2021 - 13.01.2026
13.01.2021 13.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 9.84% | |
|---|---|---|
| Roche Holding AG | 9.35% | |
| Nestle SA | 7.32% | |
| Compagnie Financiere Richemont SA Class A | 6.64% | |
| UBS Group AG Registered Shares | 6.43% | |
| ABB Ltd | 4.94% | |
| Zurich Insurance Group AG | 4.75% | |
| Holcim Ltd | 4.57% | |
| Swiss Re AG | 3.59% | |
| Swiss Life Holding AG | 3.52% | |
| Last data update | 30.09.2025 | |
| TER *** | 2.192% |
|---|---|
| TER date *** | 30.11.2025 |
| Performance Fee *** | 20.00% |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |